Subretinal tissue plasminogen activator injection to treat submacular haemorrhage during age-related macular degeneration

Acta Ophthalmol. 2014 Sep;92(6):e497-8. doi: 10.1111/aos.12458. Epub 2014 Jun 18.

Authors

Evelien Dewilde¹, Lien Delaere, Isaline Vaninbroukx, Joachim Van Calster, Peter Stalmans

Affiliation

¹ Department of Opthalmology, University Hospitals Leuven, Leuven, Belgium.

PMID: 24943231
DOI: 10.1111/aos.12458

No abstract available

Publication types

Letter

MeSH terms

Aged
Angiogenesis Inhibitors / therapeutic use
Fibrinolytic Agents / therapeutic use*
Humans
Intraoperative Complications
Intravitreal Injections
Macular Degeneration / complications
Macular Degeneration / drug therapy*
Macular Degeneration / physiopathology
Retinal Hemorrhage / drug therapy*
Retinal Hemorrhage / etiology
Retinal Hemorrhage / physiopathology
Tissue Plasminogen Activator / therapeutic use*
Vascular Endothelial Growth Factor A / antagonists & inhibitors
Visual Acuity / physiology
Vitrectomy

Substances

Angiogenesis Inhibitors
Fibrinolytic Agents
VEGFA protein, human
Vascular Endothelial Growth Factor A
Tissue Plasminogen Activator